These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 17703068)

  • 1. Molecular basis for HEF1/NEDD9/Cas-L action as a multifunctional co-ordinator of invasion, apoptosis and cell cycle.
    Singh M; Cowell L; Seo S; O'Neill G; Golemis E
    Cell Biochem Biophys; 2007; 48(1):54-72. PubMed ID: 17703068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preclinical and clinical studies of the NEDD9 scaffold protein in cancer and other diseases.
    Shagisultanova E; Gaponova AV; Gabbasov R; Nicolas E; Golemis EA
    Gene; 2015 Aug; 567(1):1-11. PubMed ID: 25967390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crk-associated substrate lymphocyte type regulates myeloid cell motility and suppresses the progression of leukemia induced by p210Bcr/Abl.
    Seo S; Nakamoto T; Takeshita M; Lu J; Sato T; Suzuki T; Kamikubo Y; Ichikawa M; Noda M; Ogawa S; Honda H; Oda H; Kurokawa M
    Cancer Sci; 2011 Dec; 102(12):2109-17. PubMed ID: 21848808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new central scaffold for metastasis: parsing HEF1/Cas-L/NEDD9.
    O'Neill GM; Seo S; Serebriiskii IG; Lessin SR; Golemis EA
    Cancer Res; 2007 Oct; 67(19):8975-9. PubMed ID: 17908996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tyrosine Y189 in the substrate domain of the adhesion docking protein NEDD9 is conserved with p130Cas Y253 and regulates NEDD9-mediated migration and focal adhesion dynamics.
    Baquiran JB; Bradbury P; O'Neill GM
    PLoS One; 2013; 8(7):e69304. PubMed ID: 23874939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nedd9/Hef1/Cas-L mediates the effects of environmental pollutants on cell migration and plasticity.
    Bui LC; Tomkiewicz C; Chevallier A; Pierre S; Bats AS; Mota S; Raingeaud J; Pierre J; Diry M; Transy C; Garlatti M; Barouki R; Coumoul X
    Oncogene; 2009 Oct; 28(41):3642-51. PubMed ID: 19648964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NEDD9 is a positive regulator of epithelial-mesenchymal transition and promotes invasion in aggressive breast cancer.
    Kong C; Wang C; Wang L; Ma M; Niu C; Sun X; Du J; Dong Z; Zhu S; Lu J; Huang B
    PLoS One; 2011; 6(7):e22666. PubMed ID: 21829474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of invasive behavior by vascular endothelial growth factor is HEF1-dependent.
    Lucas JT; Salimath BP; Slomiany MG; Rosenzweig SA
    Oncogene; 2010 Aug; 29(31):4449-59. PubMed ID: 20498643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphorylation of human enhancer filamentation 1 (HEF1) stimulates interaction with Polo-like kinase 1 leading to HEF1 localization to focal adhesions.
    Lee KH; Hwang JA; Kim SO; Kim JH; Shin SC; Kim EE; Lee KS; Rhee K; Jeon BH; Bang JK; Cha-Molstad H; Soung NK; Jang JH; Ko SK; Lee HG; Ahn JS; Kwon YT; Kim BY
    J Biol Chem; 2018 Jan; 293(3):847-862. PubMed ID: 29191835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human enhancer of filamentation 1 Is a mediator of hypoxia-inducible factor-1alpha-mediated migration in colorectal carcinoma cells.
    Kim SH; Xia D; Kim SW; Holla V; Menter DG; Dubois RN
    Cancer Res; 2010 May; 70(10):4054-63. PubMed ID: 20442290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dissection of HEF1-dependent functions in motility and transcriptional regulation.
    Fashena SJ; Einarson MB; O'Neill GM; Patriotis C; Golemis EA
    J Cell Sci; 2002 Jan; 115(Pt 1):99-111. PubMed ID: 11801728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel Cas family member, HEPL, regulates FAK and cell spreading.
    Singh MK; Dadke D; Nicolas E; Serebriiskii IG; Apostolou S; Canutescu A; Egleston BL; Golemis EA
    Mol Biol Cell; 2008 Apr; 19(4):1627-36. PubMed ID: 18256281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human enhancer of filamentation 1-induced colorectal cancer cell migration: Role of serine phosphorylation and interaction with the breast cancer anti-estrogen resistance 3 protein.
    Ibrahim R; Lemoine A; Bertoglio J; Raingeaud J
    Int J Biochem Cell Biol; 2015 Jul; 64():45-57. PubMed ID: 25817040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CAS proteins in normal and pathological cell growth control.
    Tikhmyanova N; Little JL; Golemis EA
    Cell Mol Life Sci; 2010 Apr; 67(7):1025-48. PubMed ID: 19937461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PP2A phosphatase suppresses function of the mesenchymal invasion regulator NEDD9.
    Bradbury P; Mahmassani M; Zhong J; Turner K; Paul A; Verrills NM; O'Neill GM
    Biochim Biophys Acta; 2012 Feb; 1823(2):290-7. PubMed ID: 22061964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual Targeting of Mesenchymal and Amoeboid Motility Hinders Metastatic Behavior.
    Jones BC; Kelley LC; Loskutov YV; Marinak KM; Kozyreva VK; Smolkin MB; Pugacheva EN
    Mol Cancer Res; 2017 Jun; 15(6):670-682. PubMed ID: 28235899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced genetic instability and dasatinib sensitivity in mammary tumor cells lacking NEDD9.
    Singh MK; Izumchenko E; Klein-Szanto AJ; Egleston BL; Wolfson M; Golemis EA
    Cancer Res; 2010 Nov; 70(21):8907-16. PubMed ID: 20940402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrin signalling adaptors: not only figurants in the cancer story.
    Cabodi S; del Pilar Camacho-Leal M; Di Stefano P; Defilippi P
    Nat Rev Cancer; 2010 Dec; 10(12):858-70. PubMed ID: 21102636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Focal adhesion kinase regulates beta1 integrin-dependent T cell migration through an HEF1 effector pathway.
    van Seventer GA; Salmen HJ; Law SF; O'Neill GM; Mullen MM; Franz AM; Kanner SB; Golemis EA; van Seventer JM
    Eur J Immunol; 2001 May; 31(5):1417-27. PubMed ID: 11465098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. siRNA Suppression of NEDD9 Inhibits Proliferation and Enhances Apoptosis in Renal Cell Carcinoma.
    Wang J; Yang WJ; Sun C; Luan Y; Cheng GH; Li KL; Kong F
    Oncol Res; 2014; 22(4):219-224. PubMed ID: 26351211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.